DC/NK Cell Therapy (National Taiwan University Clinical Trial Center)

N/A

Report date: 2025/10/09 20:00:09

Base Information

Drug NameDC/NK Cell Therapy (National Taiwan University Clinical Trial Center)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionNatural killer cell replacementsDendritic cells modulators
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Taiwan University Clinical Trial Center
China Registration ClassN/A

Develop Information

Active CompaniesNational Taiwan University Hospital, Yun-Lin BranchNational Taiwan University Clinical Trial Center
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A